Thiel Karl
Nat Biotechnol. 2004 Jan;22(1):31-6. doi: 10.1038/nbt0104-31.
As antibiotic resistant bacteria threaten a public health crisis, biotechnology is turning to bacteriophages, nature's tiniest viruses. But can phage therapy overcome its historical baggage?
随着抗生素耐药细菌威胁到一场公共卫生危机,生物技术领域正将目光转向噬菌体,即自然界中最小的病毒。但噬菌体疗法能否摆脱其历史包袱呢?